• Dissemination

Study References

1. Menendez C, Ferenchick E, Roman E, Bardaji A and Mangiaterra V., Malaria in pregnancy: challenges for control and the need for urgent action. The Lancet Global health. 2015; 3:e433-4.
2. WHO. Malaria and HIV interactions and their implications for public health policy WHO. 2005; ISBN 92 4 1593350.
3. WHO. WHO Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). World Health Organization Geneva. 2013 (revised 2014); WHO/HTM/GMP/2014.4.
4. Gonzalez R, Sevene E, Jagoe G, Slutsker L and Menendez C. A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected. PLoS Med. 2016; 13:e1002014.
5. Sevene E, Gonzalez R and Menendez C. Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy. Expert Opin Pharmacother. 2010; 11:1277-93.
6. Gonzalez R, Desai M, Macete E. Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo- Controlled Trial. PLoS Med. 2014; 11:e1001735.
7. WHO. Guidelines for the treatment of malaria. Second edition. WHO. 2010; ISBN 9789241547925.
8. MALTEM. Mozambican Alliance Towards the Elimination of Malaria. 2014;

Project Scientific Publications